As Of	Filer	Filing¹	For·On·As	Docs:Size	Issuer		Filing Agent

 4/15/24  Calidi Biotherapeutics, Inc.      S-1/A                 96:16M                                    M2 Compliance LLC/FA     
  4/8/24  Calidi Biotherapeutics, Inc.      S-1/A                 98:16M                                    M2 Compliance LLC/FA     
  4/2/24  Calidi Biotherapeutics, Inc.      S-1/A                  4:444K                                   M2 Compliance LLC/FA     
  4/1/24‡ Calidi Biotherapeutics, Inc.      S-1/A       3/29/24   96:16M                                    M2 Compliance LLC/FA     
  2/7/24  Calidi Biotherapeutics, Inc.      S-1/A                 94:21M                                    M2 Compliance LLC/FA     
11/14/23  Calidi Biotherapeutics, Inc.      10-Q        9/30/23   83:11M                                    M2 Compliance LLC/FA     
  5/5/23  Eterna Therapeutics Inc.          8-K:5,9      5/2/23   11:223K                                   Broadridge Fin’l So… Inc 
 4/17/23‡ Eterna Therapeutics Inc.          S-1         4/14/23    5:475K                                   Broadridge Fin’l So… Inc 
 4/11/23  Eterna Therapeutics Inc.          8-K:1,3,9    4/5/23   12:581K                                   Broadridge Fin’l So… Inc 
 3/20/23  Eterna Therapeutics Inc.          8-K:2,7,9   3/20/23   11:339K                                   Broadridge Fin’l So… Inc 
 3/20/23  Eterna Therapeutics Inc.          POS AM                 3:324K                                   Broadridge Fin’l So… Inc 
 3/20/23  Eterna Therapeutics Inc.          10-K       12/31/22  105:12M                                    Broadridge Fin’l So… Inc 
 2/22/23  Eterna Therapeutics Inc.          8-K:1,9     2/20/23   11:414K                                   Broadridge Fin’l So… Inc 
 1/26/23  Eterna Therapeutics Inc.          8-K:5       1/20/23   10:150K                                   Broadridge Fin’l So… Inc 
 1/10/23  Eterna Therapeutics Inc.          8-K:3        1/9/23   10:152K                                   Broadridge Fin’l So… Inc 
  1/4/23  Eterna Therapeutics Inc.          8-K:3,5,9  12/29/22   11:242K                                   Broadridge Fin’l So… Inc 
 12/6/22  Eterna Therapeutics Inc.          8-K:1      11/30/22   10:153K                                   Broadridge Fin’l So… Inc 
 12/5/22  Eterna Therapeutics Inc.          8-K:1,9     12/2/22   12:484K                                   Broadridge Fin’l So… Inc 
11/25/22  Eterna Therapeutics Inc.          8-K:1,3,9  11/23/22   11:582K                                   Broadridge Fin’l So… Inc 
11/23/22  Eterna Therapeutics Inc.          8-K:3      11/22/22   10:153K                                   Broadridge Fin’l So… Inc 

____________
‡	A non-Insider-Ownership Filing that was accepted after the SEC “closed” at 5:30:00pm ET.  The legal “Filed As Of” date may be the next, or another, day.
¹	Filing/Form Types:  -Q
	8-K	Current Report — Form 8-K { Item 1: Business & Operations;  2: Financial Info;  3: Securities & Trading;  4: Accountants & Accounting;  5: Governance & Management;  6: Asset-Backed Securities;  7: Disclosures;  8: Events;  9: Financials }.
	10-K	Annual Report — Form 10-K.
	10-Q	Quarterly Report — Form 10-Q.
	POS AM	Post-Effective Amendment of a Registration Statement.
	S-1	Registration Statement (General Form) — Form S-1.
	/A	Amendment to, or Amended version of, a previous Filing of this Type.